BioPhausia is a Nordic Specialty Pharma company.
 The company provides cost-effective pharmaceuticals and focuses on three fields: generic products, niche products and original drugs.
News
2009-11-23
Interim report January - September 2009
2009-09-01
Interim report January – June 2009
Read all press releases

Share information
BioPhausia is listed on the OMX Nordic exchange Stockholm AB, Small cap

BioPhausia at NASDAQ OMX  




Prospectus 2009
Calendar
  • Year End report January - December 2009, 12 February 2010
  • Interim report January - March 2010, 7 May 2010
  • Annual Genral Meeting 2010; 11 May 2010